It also happens in the very real, flesh and blood of academic medicine. So in 1980, some researchers did a study on a drug called lorcainide, and this was an anti-arrhythmic drug, a drug that suppresses abnormal heart rhythms, and the idea was, after people have had a heart attack, they're quite likely to have abnormal heart rhythms, so if we give them a drug that suppresses abnormal heart rhythms, this will increase the chances of them surviving.
사람이 실험 대상이 되는 의학계에서도 마찬가지 입니다. 1980년에 몇몇 연구자들이 불규칙적인 심장박동 억제 작용을 하는 Lorcainide라는 항부정맥제를 연구를 했는데요, 심장마비를 겪은 환자들에게 불규칙적인 심장박동 리듬을 고칠 수 있는 약을 제공하여 그들의 생존율을 높이고자 했었죠.